HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Human T cell lymphotropic virus type 1-associated myelopathy in São Paulo, Brazil. Epidemiologic and clinical features of a university hospital cohort.

Abstract
We report epidemiologic and clinical features of human T cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis in a Brazilian cohort of 86 patients from a university hospital. Cerebrospinal fluid (CSF) abnormalities and magnetic resonance imaging (MRI) findings were correlated with neurologic signs and symptoms. The patients' mean age at disease onset was 43.2 years and the female to male ratio 1.5:1. Risk factors for retroviral exposure included blood transfusions, sexual transmission and intravenous drug use. Neurologic manifestations consisted mostly of spastic paraparesis, of gradual and asymmetric onset, with increased deep-tendon reflexes. Disability was associated with disease duration. CSF findings included mild mononuclear pleocytosis and elevated protein levels. MRI showed hemispheric areas of high signal intensity in 32.7% and spinal cord atrophy in 5.6% of cases, particularly in patients with longer duration of disease. A high frequency of past blood transfusion (32.6%) suggests that blood-borne infection was an important means of HTLV infection before implementation of screening of blood donors in Brazil.
AuthorsAntonio C P Milagres, Maria Lúcia S G Jorge, Paulo E Marchiori, Alusio A C Segurado
JournalNeuroepidemiology (Neuroepidemiology) 2002 May-Jun Vol. 21 Issue 3 Pg. 153-8 ISSN: 0251-5350 [Print] Switzerland
PMID12006779 (Publication Type: Journal Article)
CopyrightCopyright 2002 S. Karger AG, Basel
Topics
  • Adult
  • Aged
  • Brain (pathology)
  • Brazil (epidemiology)
  • Cohort Studies
  • Female
  • Hospitals, University
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Paraparesis, Tropical Spastic (cerebrospinal fluid, epidemiology, pathology)
  • Risk Factors
  • Spinal Cord (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: